0001123292-18-000423.txt : 20180228 0001123292-18-000423.hdr.sgml : 20180228 20180228103417 ACCESSION NUMBER: 0001123292-18-000423 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHANG LINDA L CENTRAL INDEX KEY: 0001535179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 18648622 MAIL ADDRESS: STREET 1: ONE PARK PLACE STREET 2: STE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-02-26 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001535179 CHANG LINDA L 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Chief Financial Officer Incentive Stock Option (right to buy) 8.92 2018-02-26 4 A 0 20000 8.92 A 2019-02-26 2028-02-25 Common Stock 20000 20000 D 5,000 shares underlying this option shall vest on each of February 26, 2019, February 26, 2020, February 26, 2021 and February 26, 2022, subject to Reporting Person's continued service through the applicable vesting date. /s/ Linda L. Chang 2018-02-28